FI916077A0 - Ej glykosylerade proteiner som aer analoga med humant interleukin 3. - Google Patents
Ej glykosylerade proteiner som aer analoga med humant interleukin 3.Info
- Publication number
- FI916077A0 FI916077A0 FI916077A FI916077A FI916077A0 FI 916077 A0 FI916077 A0 FI 916077A0 FI 916077 A FI916077 A FI 916077A FI 916077 A FI916077 A FI 916077A FI 916077 A0 FI916077 A0 FI 916077A0
- Authority
- FI
- Finland
- Prior art keywords
- glycosylerade
- proteiner
- humant
- analoga
- interleukin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/5403—IL-3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/82—Proteins from microorganisms
- Y10S530/823—Lower fungi, e.g. mold
- Y10S530/824—Yeasts
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/14—Lymphokine; related peptides
- Y10S930/141—Interleukin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Veterinary Medicine (AREA)
- Toxicology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Physics & Mathematics (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Gastroenterology & Hepatology (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/374,667 US5128450A (en) | 1989-06-30 | 1989-06-30 | Nonglycosylated human interleukin-3 analog proteins |
PCT/US1990/003345 WO1991000350A1 (en) | 1989-06-30 | 1990-06-13 | Nonglycosylated human interleukin-3 analog proteins |
Publications (1)
Publication Number | Publication Date |
---|---|
FI916077A0 true FI916077A0 (fi) | 1991-12-20 |
Family
ID=23477728
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI916077A FI916077A0 (fi) | 1989-06-30 | 1991-12-20 | Ej glykosylerade proteiner som aer analoga med humant interleukin 3. |
Country Status (12)
Country | Link |
---|---|
US (1) | US5128450A (ja) |
EP (1) | EP0482013B1 (ja) |
JP (1) | JPH04506342A (ja) |
AT (1) | ATE138099T1 (ja) |
AU (1) | AU630207B2 (ja) |
CA (1) | CA2033182A1 (ja) |
DE (1) | DE69027031T2 (ja) |
DK (1) | DK0482013T3 (ja) |
ES (1) | ES2090135T3 (ja) |
FI (1) | FI916077A0 (ja) |
NO (1) | NO301482B1 (ja) |
WO (1) | WO1991000350A1 (ja) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5714585A (en) * | 1987-10-26 | 1998-02-03 | Sterling Winthrop, Inc. | Antibodies that are immunoreactive with interleukin-7 |
US5328988A (en) * | 1987-10-26 | 1994-07-12 | Immunex Corporation | Interleukin-7 |
US5705362A (en) * | 1992-05-25 | 1998-01-06 | Gist-Brocades, N.V. | Modified signal sequences |
US5463029A (en) * | 1992-11-23 | 1995-10-31 | Immunex Corporation | Purification of fusion proteins comprising GM-CSF and IL-3 |
US6403076B1 (en) | 1992-11-24 | 2002-06-11 | S. Christopher Bauer | Compositions for increasing hematopoiesis with interleukin-3 mutants |
US5738849A (en) * | 1992-11-24 | 1998-04-14 | G. D. Searle & Co. | Interleukin-3 (IL-3) variant fusion proteins, their recombinant production, and therapeutic compositions comprising them |
US6361976B1 (en) | 1992-11-24 | 2002-03-26 | S. Christopher Bauer | Co-administration of interleukin-3 mutant polypeptides with CSF'S for multi-lineage hematopoietic cell production |
US5772992A (en) * | 1992-11-24 | 1998-06-30 | G.D. Searle & Co. | Compositions for co-administration of interleukin-3 mutants and other cytokines and hematopoietic factors |
EP1283264A3 (en) * | 1992-11-24 | 2004-03-10 | G.D. Searle & Co. | Interleukin-3 (IL-3) mutant polypeptides |
US6153183A (en) | 1992-11-24 | 2000-11-28 | G. D. Searle & Company | Co-administration of interleukin-3 mutant polypeptides with CSF's or cytokines for multi-lineage hematopoietic cell production |
US5501962A (en) * | 1993-06-21 | 1996-03-26 | G. D. Searle & Co. | Interleuken-3 (IL-3) human/murine hybrid polypeptides and recombinant production of the same |
WO1995013089A1 (en) * | 1993-11-10 | 1995-05-18 | Henry M. Jackson Foundation For The Advancement Of Military Medicine | Compositions and method for stimulating antibody release by b lymphocytes |
US6017523A (en) * | 1995-06-06 | 2000-01-25 | G.D. Searle & Co. | Therapeutic methods employing mutant human interleukin-3 (IL-3) polypeptides |
JP4790911B2 (ja) | 1999-01-13 | 2011-10-12 | アルケミア オンコロジー ピーティワイ リミテッド | 薬物の効力を増強するための組成物および方法 |
AUPQ879500A0 (en) * | 2000-07-14 | 2000-08-10 | Meditech Research Limited | Hyaluronan as cytotoxic agent, drug presensitizer and chemo-sensitizer in the treatment of disease |
US9066919B2 (en) * | 2000-07-14 | 2015-06-30 | Alchemia Oncology Pty Limited | Hyaluronan as a chemo-sensitizer in the treatment of cancer |
JP2004537506A (ja) | 2001-03-01 | 2004-12-16 | ホリス − イーデン ファーマスーティカルズ、 インコーポレイテッド | 血液細胞欠乏症を治療するためのある種のステロイドの使用 |
CA2458856C (en) * | 2001-08-27 | 2011-02-15 | Meditech Research Limited | Improved therapeutic protocols |
JP4212827B2 (ja) * | 2002-05-16 | 2009-01-21 | シスメックス株式会社 | 骨髄液有核細胞自動分析方法 |
AU2003278744B2 (en) | 2002-08-28 | 2010-07-29 | Harbor Biosciences, Inc. | Therapeutic treatment methods |
JP2008527981A (ja) * | 2005-01-25 | 2008-07-31 | アポロ ライフ サイエンシズ リミテッド | 治療目的および診断目的のためにパラメーターにより選択されたgm−csf、il−3、il−4、il−5、ならびにそのキメラ |
AU2006274509B2 (en) * | 2005-07-27 | 2012-01-19 | Alchemia Oncology Pty Limited | Therapeutic protocols using hyaluronan |
CN101287475B (zh) * | 2005-09-07 | 2012-11-14 | 阿尔卡米亚肿瘤学股份有限公司 | 包含透明质酸和治疗抗体的治疗组合物以及制药用途 |
JP5628544B2 (ja) * | 2010-04-07 | 2014-11-19 | 株式会社豊田中央研究所 | クロストリジウム・サーモセラム由来のタンパク質複合体を構築するためのタンパク質及びその利用 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4695542A (en) * | 1983-10-04 | 1987-09-22 | Dnax Research Institute Of Molecular And Cellular Biology, Inc. | cDNA clones coding for polypeptides exhibiting multi-lineage cellular growth factor activity |
US4877729A (en) * | 1986-07-14 | 1989-10-31 | Genetics Institute, Inc. | Recombinant DNA encoding novel family of primate hematopoietic growth factors |
NZ222939A (en) * | 1986-12-16 | 1991-03-26 | Gist Brocades Nv | Human interleukin-3, production using genetic engineering methods, antibodies to human interleukin-3 and screening of dna library with 3' untranslated region |
EP0790307A1 (en) * | 1986-12-16 | 1997-08-20 | Gist-Brocades B.V. | Molecular cloning and expression of human IL-3 |
JPH02501925A (ja) * | 1987-01-20 | 1990-06-28 | イミュネックス・コーポレーション | ヒト インターロイキン‐3 蛋白質 |
OA09736A (en) * | 1987-02-18 | 1993-11-30 | Schering Biotech Corp | "Human interleukin-3 and muteins thereof". |
JPH04500508A (ja) * | 1988-07-20 | 1992-01-30 | イミュネックス・コーポレーション | 非グリコシル化 ヒト インターロイキン―3 組成物 |
-
1989
- 1989-06-30 US US07/374,667 patent/US5128450A/en not_active Expired - Lifetime
-
1990
- 1990-06-13 DK DK90909318.9T patent/DK0482013T3/da active
- 1990-06-13 AT AT90909318T patent/ATE138099T1/de not_active IP Right Cessation
- 1990-06-13 DE DE69027031T patent/DE69027031T2/de not_active Expired - Fee Related
- 1990-06-13 JP JP2508883A patent/JPH04506342A/ja active Pending
- 1990-06-13 EP EP90909318A patent/EP0482013B1/en not_active Expired - Lifetime
- 1990-06-13 AU AU58216/90A patent/AU630207B2/en not_active Ceased
- 1990-06-13 WO PCT/US1990/003345 patent/WO1991000350A1/en active IP Right Grant
- 1990-06-13 ES ES90909318T patent/ES2090135T3/es not_active Expired - Lifetime
- 1990-06-13 CA CA002033182A patent/CA2033182A1/en not_active Abandoned
-
1991
- 1991-12-20 FI FI916077A patent/FI916077A0/fi not_active Application Discontinuation
- 1991-12-27 NO NO915116A patent/NO301482B1/no unknown
Also Published As
Publication number | Publication date |
---|---|
AU5821690A (en) | 1991-01-17 |
ES2090135T3 (es) | 1996-10-16 |
EP0482013B1 (en) | 1996-05-15 |
EP0482013A1 (en) | 1992-04-29 |
JPH04506342A (ja) | 1992-11-05 |
DK0482013T3 (da) | 1996-06-03 |
NO915116D0 (no) | 1991-12-27 |
US5128450A (en) | 1992-07-07 |
DE69027031D1 (de) | 1996-06-20 |
ATE138099T1 (de) | 1996-06-15 |
NO301482B1 (no) | 1997-11-03 |
CA2033182A1 (en) | 1990-12-31 |
WO1991000350A1 (en) | 1991-01-10 |
AU630207B2 (en) | 1992-10-22 |
NO915116L (no) | 1992-02-28 |
DE69027031T2 (de) | 1996-12-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI916077A0 (fi) | Ej glykosylerade proteiner som aer analoga med humant interleukin 3. | |
IL85523A (en) | Stable alpha interferon complex,its preparation and pharmaceutical compositions comprising it | |
ATE380037T1 (de) | Verfaheren zur durch rekombinante adeno- assoziierte virus-gerichtete gentherapie | |
ATE204178T1 (de) | Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin | |
AU6701890A (en) | Process for the production of biologically active protein | |
NO952744D0 (no) | Cytokinbegrensende midler | |
DK581185D0 (da) | Farmaceutisk praeparat indeholdende 13-cis-a-vitaminsyre | |
PT89534A (pt) | Processo para a preparacao de composicoes farmaceuticas anticoagulantes contendo como ingrediente activo proteina c ou proteina c activada combinada com heparina | |
PL316942A1 (en) | Novel pharmaceutic compositions based on taxoides | |
DE69024104T2 (de) | Polypeptide und Polypeptidanaloge mit inhibitorischer Aktivität gegenüber menschlicher Elastase | |
ID820B (id) | Turunan benzisotiazolinon-1-dioksid sebagai penghambat elastase | |
HUP9602498A2 (hu) | Antimikrobiális hatású gyógyászati készítmények | |
EP0225020A3 (en) | Peptides comprising, in sequence, units selected from the amino-acid residues 17 to 24 of vip | |
AU2308992A (en) | Cysteine depleted il-6 muteins | |
ATE323724T1 (de) | Mpl-liganden analoga | |
KR910005886A (ko) | 안정화 백혈구 인터페론 | |
KR960700741A (ko) | 인터페론치료에 대한 무응답자의 c형 간염 치료방법(method of treating hepatitis c in non-pesponders to interferon treatment) | |
IE871358L (en) | Interferon for carcinoma | |
EP0820771A3 (de) | Arzneimittel zur Behandlung von Neuropathien, das ein lipidlösliches Thiamin und eine Magnesiumverbindung enthält | |
ES2073063T3 (es) | Formulaciones galenicas acuosas de eritropoyetina y su uso. | |
JPS6429A (en) | Antiviral agent | |
SE8704049D0 (sv) | Novel pharmacological compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD | Application lapsed |